The specific aims of this 5 year program-based collaborative research project are to: 1. evaluate and compare the effects of a relapse prevention/health education program and Therapeutic Community on completion rates, retention rates, and behavioral outcomes; 2) evaluate and compare the effects of a three-month relapse prevention-health education program and a six-month relapse program on prevention/health education on retention rates, completion rates, and HIV-related behaviors): 3. evaluate and compare the effects of a six-month Therapeutic Community and an one year Therapeutic Community (treatment as usual on completion rate, and behavioral outcomes: and 4. evaluate and compare the effectiveness of the programs outlined above in reducing AIDS-risk behavior in program participants. The study comprises two controlled clinical trials and an observational study. Approximately 600 clients applying to Spectrum House and Marathon, Inc. respectively (total of 1,200 participants) will be recruited and then randomized to one of the two relapse programs (3 or 6 months) for Spectrum clients and one of two Therapeutic Community intervention (6 to 12 months) for Marathon, Inc. clients. This research will 1) document pre-treatment behaviors and treatment history; 2) document program processes, retention, and completion rates: and 3) explore the relationships between program length, program type, and behavioral outcomes at 3 and 12 months after discharge. We hypothesize that 10 the relapse program will be more effective than the Therapeutic Community in reducing relapse rates and other behavioral outcomes because a) it acknowledges the chronicity of drug abuse and b) it provides specific skills needed to anticipate triggers to relapse and to deal effectively with them: 2) that short term treatment will have higher retention and completion rates compared to long term treatment: and 3) among those completing the programs, long term treatment will be more effective in terms of relapse rates. The research will also explore relationships between demographic and other variables (age,sex, race, HIV status, baseline psychological profile, socioeconomic status, previous drug treatment, legal history, and educational/vocational history) and retention rates, completion rates, and behaviors after treatment.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Research Demonstration and Dissemination Projects (R18)
Project #
5R18DA006151-04
Application #
2118456
Study Section
Special Emphasis Panel (SRCD (02))
Project Start
1989-09-30
Project End
1994-08-31
Budget Start
1992-09-25
Budget End
1993-08-31
Support Year
4
Fiscal Year
1992
Total Cost
Indirect Cost
Name
Phoenix Houses of New England, Inc.
Department
Type
DUNS #
City
Providence
State
RI
Country
United States
Zip Code
02906
O'Malley, Stephanie S; Wu, Ran; Mayne, Susan T et al. (2014) Smoking cessation is followed by increases in serum bilirubin, an endogenous antioxidant associated with lower risk of lung cancer and cardiovascular disease. Nicotine Tob Res 16:1145-9
Goldstein, R B; Bigelow, C; McCusker, J et al. (2001) Antisocial behavioral syndromes and return to drug use following residential relapse prevention/health education treatment. Am J Drug Alcohol Abuse 27:453-82
Goldstein, R B; Powers, S I; McCusker, J et al. (1999) Antisocial behavioral syndromes among residential drug abuse treatment clients. Drug Alcohol Depend 53:171-87
Goldstein, R B; Powers, S I; McCusker, J et al. (1998) Antisocial behavioral syndromes among residential drug abuse treatment clients. Drug Alcohol Depend 49:201-16
McCusker, J; Bigelow, C; Vickers-Lahti, M et al. (1997) Planned duration of residential drug abuse treatment: efficacy versus effectiveness. Addiction 92:1467-78
McCusker, J; Bigelow, C; Frost, R et al. (1997) The effects of planned duration of residential drug abuse treatment on recovery and HIV risk behavior. Am J Public Health 87:1637-44
McCusker, J; Stoddard, A; Frost, R et al. (1996) Planned versus actual duration of drug abuse treatment. Reconciling observational and experimental evidence. J Nerv Ment Dis 184:482-9
Goldstein, R B; Powers, S I; McCusker, J et al. (1996) Gender differences in manifestations of antisocial personality disorder among residential drug abuse treatment clients. Drug Alcohol Depend 41:35-45
De Irala, J; Bigelow, C; McCusker, J et al. (1996) Reliability of self-reported human immunodeficiency virus risk behaviors in a residential drug treatment population. Am J Epidemiol 143:725-32
Spotts, D; Hindin, R; Garfield, F et al. (1996) Strategies for follow-up of drug users: field research guidelines. Subst Use Misuse 31:1891-927

Showing the most recent 10 out of 16 publications